日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of elranatamab in patients with relapsed and/or refractory immunoglobulin light-chain amyloidosis

elranatamab治疗复发和/或难治性免疫球蛋白轻链淀粉样变性患者的安全性和有效性

Vianna, Pedro; Chakraborty, Rajshekhar; Hossain, Shahrier; Bhutani, Divaya; Miller, Shannon; Rossi, Annemarie; Cuddy, Sarah A M; Falk, Rodney H; Lentzsch, Suzanne; Laubach, Jacob P; Bianchi, Giada

Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era

AL淀粉样变性血液学反应动力学:达雷妥尤单抗时代临床和细胞遗传学亚组分析的启示

Bazarbachi, Abdul-Hamid; Zanwar, Saurabh; Hegenbart, Ute; Trajanova, Despina; Bhutani, Divaya; Gertz, Morie A; Dispenzieri, Angela; Kumar, Shaji; D'Souza, Anita; Patwari, Anannya; Cowan, Andrew; Chen, GuiZhen; Milani, Paolo; Palladini, Giovanni; Sanchorawala, Vaishali; Bodanapu, Geethika; Mohty, Mohamad; Lentzsch, Suzanne; Schönland, Stefan O; Muchtar, Eli; Chakraborty, Rajshekhar

Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma

静脉注射免疫球蛋白(IVIG)补充剂对接受BCMA靶向双特异性抗体治疗的多发性骨髓瘤患者无感染生存期的影响

Mohan, Meera; Szabo, Aniko; Cheruvalath, Heloise; Clennon, Anna; Bhatlapenumarthi, Vineel; Patwari, Anannya; Balev, Metodi; Bhutani, Divaya; Shrestha, Asis; Thanendrarajan, Sharmilan; Dhakal, Binod; Zangari, Maurizio; Trikannad, Anup; Vellanki, Sruthi; Al-Hadidi, Samer; Lentzsch, Suzanne; van Rhee, Frits; Bag, Aishee; D'Souza, Anita; Shah, Nishi; Chakraborty, Rajshekhar; Shah, Mansi R; Schinke, Carolina

Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study

塔奎他单抗治疗复发难治性多发性骨髓瘤:多中心真实世界研究

Al Hadidi, Samer; Szabo, Aniko; Mohan Lal, Bhavesh; Bag, Aishee; Zhen, Simon; Ogunsesan, Yetunde; Annyapu, Evanka; Dhakal, Binod; Bhutani, Divaya; Thanendrarajan, Sharmilan; Zangari, Maurizio; D'Souza, Anita; Lentzsch, Suzanne; van Rhee, Frits; Chakraborty, Rajshekhar; Schinke, Carolina; Mohan, Meera; Shah, Mansi R

Long-term follow-up of patients with AL amyloidosis treated on a phase 1 trial of CAEL-101

对接受 CAEL-101 治疗的 AL 淀粉样变性患者进行 1 期临床试验的长期随访

Hughes, Michael Sang; Pan, Samuel; Chakraborty, Rajshekhar; Raikhelkar, Jayant; Maurer, Mathew S; Mapara, Markus Y; Eisenberger, Andrew; Lentzsch, Suzanne; Bhutani, Divaya

Diffuse lung involvement as a rare presentation of systemic AL amyloidosis: a retrospective cohort study

弥漫性肺部受累作为系统性AL淀粉样变性的罕见表现:一项回顾性队列研究

Song, Amy; Mellgard, George; Bellofiore, Claudia; Basset, Marco; Nuvolone, Mario; Foli, Andrea; Merlini, Giampaolo; Maurer, Mathew S; Mapara, Markus Y; Bhutani, Divaya; Lentzsch, Suzanne; Shaish, Hiram; Palladini, Giovanni; Chakraborty, Rajshekhar; Milani, Paolo

Endless possibilities and how to exploit them? What is the optimal treatment sequence?

无限的可能性以及如何利用它们?最佳治疗顺序是什么?

Chakraborty, Rajshekhar; Bhutani, Divaya; Lentzsch, Suzanne

GCK inhibition enhances iberdomide antimyeloma effects by promoting IKZF1 degradation via a CRBN-independent mechanism

GCK抑制剂通过一种不依赖于CRBN的机制促进IKZF1降解,从而增强伊贝多米德的抗骨髓瘤作用。

Li, Shirong; Krüger, Josefine; Liu, Guifen; Ma, Huihui; Hughes, Michael S; Chakraborty, Rajshekhar; Bhutani, Divaya; Mapara, Markus Y; Marcireau, Christophe; Lentzsch, Suzanne; Fu, Jing

Risk stratification models overestimate progression risk in contemporary patients with smoldering multiple myeloma

风险分层模型高估了当代冒烟型多发性骨髓瘤患者的疾病进展风险。

Mellgard, George; Gilligan, Molly; Cliff, Edward R Scheffer; Bhutani, Divaya; Mohyuddin, Ghulam R; Eisenberger, Andrew; Lentzsch, Suzanne; Chakraborty, Rajshekhar

Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

特克利司他单抗治疗复发难治性多发性骨髓瘤:多中心真实世界研究

Mohan, Meera; Monge, Jorge; Shah, Nishi; Luan, Danny; Forsberg, Mark; Bhatlapenumarthi, Vineel; Balev, Metodi; Patwari, Anannya; Cheruvalath, Heloise; Bhutani, Divaya; Thanendrarajan, Sharmilan; Dhakal, Binod; Zangari, Maurizio; Al-Hadidi, Samer; Cooper, Dennis; Lentzsch, Suzanne; van Rhee, Frits; D'Souza, Anita; Szabo, Aniko; Schinke, Carolina; Chakraborty, Rajshekhar